CSF1R and acute myeloid leukemia: Gottschlich et al. utilized an atlas of publicly available RNA sequencing data from over 500,000 single cells and identified CSF1R (colony-stimulating factor 1 receptor) and CD86 (cluster of differentiation 86) as targets for CAR-T-cell therapy in AML [176].